Publication | Closed Access

Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing

VaccinationVaccine SafetyVaccine DevelopmentViral HepatitisClinical TestingImmunologyHepatitis BHepatitisVaccine DesignMedicineVaccine ResearchPhase 1